
    
      The institutional prospectively maintained database was queried, and 20 patients with
      cHCC-MFCCC were identified. A 2:1 match was performed with 40 patients operated in the same
      period for HCC, and with 40 operated for MFCCC. Only T1 or T2 patients N0 M0 were considered.
      Primary endpoint was the overall survival (OS) and disease-free survival (DFS).
    
  